U.S.-based companies are dragging down the major stock market indexes. But getting caught up in short-term market movements ...

Goldman Sachs initiated coverage of Sionna Therapeutics (SION) with an Early-Stage Biotech designation. Lead assets SION-719 and SION-451 are ...

FHLC offers diversification with 368 U.S. large-cap holdings, outperforming peer funds. See why I rate the fund a buy.

Wall Street stocks closed sharply lower on Tuesday as Donald Trump's tariffs on Canadian, Mexican and Chinese imports came ...

Vertex Pharmaceuticals secured a Buy rating from Leerink Partners analyst David Risinger. The firm’s newly approved pain ...